Nonalcoholic steatohepatitis (NASH ... This article will briefly discuss prevalence studies and the pathophysiology of NAFLD and focus on current discussions related to the specific lesions ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a liver disease that progresses without symptoms and is associated ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

Metabolic dysfunction-associated steatohepatitis (MASH ... pharmacological administration of FGF21 protects against MASH pathology at least in large through the interaction between βKlotho ...

HistoIndex, a global leader in stain-free digital pathology solutions for managing fibrotic diseases, has announced the ...

DelveInsight’s, “Nonalcoholic Steatohepatitis Pipeline Insight” report provides comprehensive insights about 80+ companies and 80+ pipeline drugs in Nonalcoholic Steatohepatitis pipeline ...

Although most of the histopathologic lesions of steatohepatitis have been agreed on, the qualitative amounts and acinar localization remain foci of interest in pathology in adults, in pediatric ...

Metabolic dysfunction-associated steatohepatitis (MASH) is a polygenic disorder influenced by multiple genes, but their ...

Metabolic dysfunction-associated steatohepatitis (MASH ... A key factor in the pathology of MASH is the disruption of endoplasmic reticulum (ER) homeostasis. The ER stores calcium ions (Ca ...